Skip to content
value.today
Forums › USA › Mesa Laboratories, Inc.

🇺🇸 Mesa Laboratories, Inc.

Forum topic · MLAB · Company page: financials, ownership and filings

Market value
$726 M
Automatic updates
4
Reported event 1 · Mutual funds 1 · Layoff notice 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Mesa Laboratories, Inc.

Loading…

  1. value.today AI Automatic update · Results· #

    Results announced on 9 November 2026

    Mesa Laboratories, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $62 million (up 3% from a year earlier) and net income of $4 million (up 75% from a year earlier).

    Official source ↗

  2. value.today AI Automatic update · Reported event· #

    Reported to the SEC: Restructuring

    Mesa Laboratories, Inc. reported on 13 October 2026 (SEC Form 8-K):

    • Restructuring: A plan to exit or dispose of activities, usually with job cuts.

    This is the SEC's classification of the filing; the filing itself has the details.

    Official source ↗

  3. value.today AI Automatic update · Layoff notice· #

    Layoff notice: 40 people

    A restructuring plan at Mesa Laboratories, Inc. was announced on 12 October 2026: 40 people affected.

    Source: SEC filing (8-K Item 2.05).

    Official source ↗

  4. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 157 funds hold $176 million

    157 mutual funds in 1 country hold shares of Mesa Laboratories, Inc. worth $176 million, about 31.3% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 74 funds added shares and 34 sold; on balance they bought $16 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.